The Koch Institute for Integrative Cancer Research at MIT

an accordion of endothelial cells stained in pink and green

Using MIT ingenuity to create knowledge, tools, and treatments to fight cancer

Our Research Areas

From fundamental discoveries to engineering advances, we strategically pursue five areas of research that, across tumor types, are critical for rapid progress toward defeating cancer.

As a National Cancer Institute-designated basic cancer research center, we produce knowledge and tools to fight one of humanity's most persistent challenges.

NCI Cancer Center: A Cancer Center Designated by the National Cancer Institute

News

Solving the puzzle of immune evasion

MIT News

Stefani Spranger’s work is focused on uncovering why some tumors evade the immune system’s attack. For example, her latest research, published in Cancer Immunology Research, reveals that lung cancer cells expressing SOX2 can block CD8+ T cells, undermining checkpoint blockade therapy. “By understanding these resistance mechanisms, we can develop smarter immunotherapies to outmaneuver cancer,” says Spranger.

At the Koch Institute for Integrative Cancer Research, scientists and engineers work together to solve some of the most difficult problems in cancer. We ask big questions in strategic areas, where the answers have big impacts on how we understand and treat cancer.